Tacton Launches Connect to Anything, Powered by Workato, Simplifying Integration for Manufacturers
21.1.2025 15:06:00 CET | Business Wire | Press release
Tacton, a global leader in Configure, Price, Quote (CPQ) software and leading SaaS platform simplifying sales and configuration processes for manufacturers of complex products, today announced the launch of its Connect to Anything integration capability, powered by Workato, the leading enterprise orchestration platform. This innovative solution transforms how manufacturers integrate Tacton CPQ into their digital ecosystems, enabling seamless connections to over 600 enterprise applications, including CRM, ERP, PLM, PIM, and analytics tools.
Manufacturers often face costly inefficiencies from data silos and integration roadblocks as IT teams struggle to keep pace with complex connections. The stakes are high: poor data quality costs organizations an average of $12.9 million annually, according to Gartner’s® 2020 Magic Quadrant™ for Data Quality Solutions. Connect to Anything solves this challenge by making it simple to connect data across applications without heavy reliance on IT. With pre-built connectors, reusable recipes, and a no-code approach, Tacton empowers manufacturers to eliminate silos, streamline workflows, and accelerate their digital transformation journey.
“As manufacturers embrace digital transformation, seamless integration across systems has become mission-critical,” saidJesper Alfredsson, Chief Product Officer, Tacton. “Connect to Anything simplifies this process by enabling manufacturers to unify their digital ecosystems, reduce IT dependency, and achieve faster, smarter operations that drive tangible business outcomes.”
With Connect to Anything, manufacturers can:
- Simplify Integration: Seamlessly connect Tacton CPQ to essential systems with pre-built connectors and no-code recipes.
- Accelerate ROI: Achieve faster implementation and operational efficiency with reduced dependency on IT.
- Maximize CPQ Value: Unlock greater returns from CPQ investments with integration capabilities available from the start of implementation.
Connect to Anything brings together unmatched innovation through this partnership. Tacton has been recognized as a Leader in the Gartner® Magic Quadrant™ for CPQ Applications, while Workato is a Leader in the Gartner® Magic Quadrant™ for Integration Platform as a Service (iPaaS). Together, these industry leaders deliver a powerful solution that helps manufacturers simplify integrations, optimize workflows, and scale operations seamlessly.
“We are thrilled to partner with Tacton, providing manufacturers with seamless integration capabilities that accelerate their journey towards smart factories,” said Nam Le, General Manager of Workato’s Embed Business. “This collaboration exemplifies how leaders in their respective industries can drive powerful outcomes for manufacturers. By embedding Workato’s no-code platform into Tacton CPQ, manufacturers gain unmatched flexibility and efficiency in connecting and optimizing their digital ecosystems. Together, we’re empowering manufacturers to build connected, agile operations that deliver real business value.”
Connect to Anything is available now for manufacturers looking to simplify and accelerate their digital transformation. To learn more about our integration capabilities, visit our website.
About Tacton
Tacton is a leading SaaS company redefining how manufacturers of complex products engage with their buyers. Its cutting-edge buyer engagement platform empowers manufacturers to streamline the buyer journey, deliver personalized, customer-centric experiences, and bring complex products to market faster and more efficiently.
Recognized as a Leader in Gartner’s® Magic Quadrant™ for CPQ Applications, Tacton partners with manufacturers to drive smart factory initiatives and align operations with customer needs. With over 25 years of experience and trusted by more than 100 global leaders like ABB, Daimler, MAN, Scania, Siemens, Xylem, and Yaskawa, Tacton is co-headquartered in Chicago and Stockholm, with regional offices in Karlsruhe, Warsaw, and Tokyo. Learn more at www.tacton.com.
About Workato
Workato transforms technology complexity into business opportunity. As the leader in enterprise orchestration, Workato helps businesses globally streamline operations by connecting data, processes, applications, and experiences. Its AI-powered platform enables teams to navigate complex workflows in real time, driving efficiency and agility. Trusted by a community of 400,000 global users, Workato empowers organizations of every size to unlock new value and lead in today’s fast-changing world. Learn how Workato helps businesses of all sizes achieve more at www.workato.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250116707013/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types13.7.2026 10:00:00 CEST | Press release
- Treatment with latarcibart led to an 81% median reduction in annualized bleeding rate (ABR) across all bleeding categories and patient types with von Willebrand disease (VWD) - Latarcibart, administered via a once monthly subcutaneous dosing regimen, was shown to be safe and well tolerated over multiple doses in this study - Pivotal Phase 3 VIVID-6 trial evaluating latarcibart’s potential to be the first targeted therapy for VWD is currently enrolling Incyte (Nasdaq: INCY) today announced complete safety and efficacy data from all patients (n=16) enrolled in the Phase 1/2 multidose study of VGA039 (latarcibart), a novel, Protein S-targeting, investigational monoclonal antibody for patients with von Willebrand disease (VWD). The data are being shared in an oral presentation today at the 34th Congress of the International Society on Thrombosis and Haemostasis (ISTH 2026 Congress) in Paris. Latarcibart modulates Protein S to improve hemostasis, potentially enhancing the body’s ability t
Europe’s Demand for Tech Services Accelerates in Q2, As Spending on AI and Managed Services Rises: ISG Index™13.7.2026 10:00:00 CEST | Press release
Combined market up 46%, led by 64% growth in cloud servicesManaged services up 21%, as companies seek cost savings to fund AI Demand for technology services in Europe continued to accelerate in the second quarter, as the region increasingly turns to managed services to reduce costs and cloud services to meet AI objectives, according to the latest state-of-the-industry report from Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm. The EMEA ISG Index™, which measures commercial outsourcing contracts with annual contract value (ACV) of US $5 million or more, shows second-quarter ACV for the combined market (both managed services and cloud-based as-a-service) soared 46 percent—its largest growth in eight years—to US $13.0 billion. The latest quarter adds to a string of three straight quarters in which growth has averaged 33 percent. “Europe has become the fastest-growing region for technology services, fueled not only by an increasin
Maureen Mahr von Staszewski Joins Heitman European Leadership Team13.7.2026 09:30:00 CEST | Press release
Heitman expands European platform with addition of experienced leader Heitman LLC (“Heitman”), a global real estate investment management firm, today announced the appointment of Maureen Mahr von Staszewski as Managing Director in the firm’s European Real Estate Investment team. As part of Heitman’s European leadership team, Maureen will help drive continued expansion across Europe, supporting the firm’s strategic growth initiatives, capital raising efforts, and investment activity across the region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260713202147/en/ Maureen Mahr von Staszewski Joins Heitman European Leadership Team “We are excited Maureen has joined the Heitman team,” said Caleb Mercer, Managing Director and Head of European Investment at Heitman. “Her breadth and depth of experience in European real estate investment management will help strengthen our innovative and differentiated investment capabilities acro
LTM Partners with Anthropic to Accelerate Claude Adoption and Expand Enterprise Delivery13.7.2026 08:16:00 CEST | Press release
Claude and Claude Code embedded into LTM BlueVerse™ AI Delivery Fabric to power AI-led transformations LTM, the Business Creativity partner to the world's largest enterprises, today announced a partnership with Anthropic, the frontier AI company behind Claude, to accelerate enterprise-scale adoption of Claude, Claude Code and Claude Cowork across engineering, modernization, and business workflows. LTM will combine Claude, Claude Code and Claude Cowork with its enterprise implementation expertise to help clients move from pilots to production with market-leading productivity, throughput, quality underscored by assurance and transparency. LTM will specifically bring this expertise and capability to BFSI, Hi-Tech, Consumer and Production Industry domains. The three strategic focus areas of partnership include:LTM BlueVerse™: AI Delivery Fabric LTM BlueVerse AI Delivery Fabric will serve as the enterprise implementation layer for Claude adoption, integrating Claude and Claude Code into del
Sofinnova Partners Appoints David Evans as Partner13.7.2026 08:00:00 CEST | Press release
Sofinnova strengthens its growth strategy with a high-caliber London-based Partner:Physician-scientist combining frontline clinical experience, health financing and policy expertise, and a proven track record in venture capitalOver 20 years in drug development at Bristol Myers Squibb, Eli Lilly, and the Roche Venture Fund as well as in healthcare policy and financing Sofinnova Partners ("Sofinnova"), a leading European venture capital firm in life sciences, based in Paris, London, and Milan, announced the appointment of David Evans as Partner. A physician-scientist with deep pharma and drug development expertise, Evans joins from the Roche Venture Fund, where he most recently served as Senior Investment Director. His career spans frontline patient care as a doctor in Australia and with Médecins Sans Frontières, health policy and financing at the World Bank, and roles across the pharmaceutical industry in health economics & outcomes research and drug development before moving into life-
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom